Effectiveness and safety profile of leflunomide in rheumatoid arthritis : actual practice compared with clinical trials

Leflunomide, an immunosuppressant agent for treating rheumatoid arthritis, was first marketed in France in 2000. Three years after its launch, we sought to assess its prescription patterns in the real world of prescription and use, and to see if its efficacy and safety profiles observed during clini...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental rheumatology 2005, Vol.23 (1), p.80-84
Hauptverfasser:	MARTIN, K, BENTABERRY, F, DUMOULIN, C, DEHAIS, J, HARAMBURU, F, BEGAUD, B, SCHAEVERBEKE, T
Format:	Artikel
Sprache:	eng
Schlagworte:	Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Biological and medical sciences Bones, joints and connective tissue. Antiinflammatory agents Clinical Trials as Topic Diseases of the osteoarticular system Drug Utilization Review Female Humans Inflammatory joint diseases Isoxazoles - therapeutic use Male Medical sciences Middle Aged Pharmacology. Drug treatments Practice Patterns, Physicians Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!